NCT06036966 2023-09-14
The Efficacy and Safety of Hetrombopag in Primary Prevention of Thrombocytopenia Induced by the Niraparib Maintenance in Advanced Ovarian Cancer Patients
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2 Unknown
Clinical Trials
11 trialsNCT05672420 2023-01-05
Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 1/2 Unknown
NCT05087459 2021-10-21
Treatment of Avatrombopag for Thrombocytopenia in Patients Undergoing Selective Resection of Hepatocellular Carcinoma
Shanghai Zhongshan Hospital
Unknown
NCT04896528 2021-05-21
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia
Peking Union Medical College Hospital
Phase 2 Unknown
NCT04797182 2021-03-15
Avatrombopag for the Primary Prevention of Thrombocytopenia Induced by Cytarabine-based Chemotherapy in Patients With Lymphoma
Sun Yat-sen University
Phase 2 Unknown
NCT03288441 2020-09-17
MATTER
Maastricht University Medical Center
Unknown
NCT03823079 2019-01-30
Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With Thrombocytopenia
Fudan University
Phase 2 Unknown
NCT03701217 2018-10-09
Eltrombopag Used in Thrombocytopenia After Comsolidation Therapy in AML
Nanfang Hospital, Southern Medical University
Phase 2/3 Unknown
NCT02093325 2017-10-24
A Study to Assess the Efficacy and Safety of Eltrombopag as a Rescue of Isolated Chemotherapy-induced Thrombocytopenia
Chang Gung Memorial Hospital
Phase 3 Unknown
NCT02781155 2016-05-24
Limiting Chemotherapy Side Effects by Using Moxa
East and North Hertfordshire NHS Trust
Phase 1/2 Unknown
NCT02244658 2016-04-20
Recombinant Human Thrombopoietin (rhTPO) in Management of Chemotherapy-induced Thrombocytopenia in Acute Myelocytic Leukemia
Shandong University
Phase 3 Unknown